Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
The Journal of Clinical Investigation
|
December 13, 2006
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Emily E Bosco, Ying Wang, Huan Xu, et al.
The Journal of Clinical Investigation
|
June 3, 2025
Immune cells promote paralytic disease in mice infected with enterovirus D68
Mikal A Woods Acevedo, Jie Lan, Sarah Maya, et al.
Chemistry & Biology
|
February 28, 2012
Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation
Emily E Bosco, Sachin Kumar, Filippo Marchioni, et al.
Cancer Research
|
June 3, 2005
Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy
Christopher N Mayhew, Emily E Bosco, Sejal R Fox, et al.
Biomacromolecules
|
May 17, 2025
Intracellular Nanodelivery of DNA with Enzyme-Degradable and pH-Responsive Peptide Dendrons
M A Urello, H J Vaughan, L T Dockery, et al.
Oncogene
|
April 25, 2007
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function
M P Markey, J Bergseid, E E Bosco, et al.
Oncotarget
|
May 26, 2018
Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer
Emily E Bosco, R James Christie, Rosa Carrasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers
Allison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
The Journal of Clinical Investigation
|
November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
Peter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
The Journal of Clinical Investigation
|
December 13, 2006
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer
Emily E Bosco, Ying Wang, Huan Xu, et al.
The Journal of Clinical Investigation
|
June 3, 2025
Immune cells promote paralytic disease in mice infected with enterovirus D68
Mikal A Woods Acevedo, Jie Lan, Sarah Maya, et al.
Chemistry & Biology
|
February 28, 2012
Rational design of small molecule inhibitors targeting the Rac GTPase-p67(phox) signaling axis in inflammation
Emily E Bosco, Sachin Kumar, Filippo Marchioni, et al.
Cancer Research
|
June 3, 2005
Liver-specific pRB loss results in ectopic cell cycle entry and aberrant ploidy
Christopher N Mayhew, Emily E Bosco, Sejal R Fox, et al.
Biomacromolecules
|
May 17, 2025
Intracellular Nanodelivery of DNA with Enzyme-Degradable and pH-Responsive Peptide Dendrons
M A Urello, H J Vaughan, L T Dockery, et al.
Oncogene
|
April 25, 2007
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function
M P Markey, J Bergseid, E E Bosco, et al.
Oncotarget
|
May 26, 2018
Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer
Emily E Bosco, R James Christie, Rosa Carrasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2024
Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers
Allison M Barrett, Zachary T Britton, Rosa A Carrasco, et al.
The Journal of Clinical Investigation
|
November 15, 2023
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer
Peter Zanvit, Dewald van Dyk, Christine Fazenbaker, et al.
Page
of 6